NCT00120003View on ClinicalTrials.gov

Scandinavian Candesartan Acute Stroke Trial (SCAST)

PHASE3CompletedINTERVENTIONAL

Enrollment

2,500

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Stroke

Interventions

DRUG

Candesartan Cilexetil

4 mg on day 1; 8 mg on day 2; 16 mg on days 3-7

DRUG

Placebo

4 mg on day 1; 8 mg on day 2; 16 mg on days 3-7

Trial Locations (1)

NO-0407

Ullevaal University Hospital, Oslo

Sponsors

Collaborators (2)

All Listed Sponsors

collaborator

Southern-Eastern Norway Health Authorities RHF

UNKNOWN

collaborator

AstraZeneca

INDUSTRY

collaborator

Takeda

INDUSTRY

lead

Ullevaal University Hospital

OTHER